In syngeneic cancer mouse models, in addition to reducing metastases, mAb 5B11B3 abates tumor growth by promoting anti-cancer immunity mediated by macrophages and CD8+ T lymphocytes (Seclì et al., 2021). The gene discussed is CD8A; the disease is cancer.